Skip to content


You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Proceedings

Open Access

Epidemiology of the first outbreak of carbapenem-resistant Klebsiella pneumoniae in Saudi Arabia

  • HH Balkhy1, 2,
  • A El-Saed1,
  • S Al Johani3,
  • HT Tayeb2,
  • A Al-Qahtani4,
  • M Alahdal4,
  • M Sallah1,
  • A Alothman5 and
  • Y Alarabi6
BMC Proceedings20115(Suppl 6):P295

Published: 29 June 2011

Introduction / objectives

We describe our experience in detecting and containing the first documented CRKP outbreak in Saudi Arabia (SA).


A prospective investigation of all cases identified with carbapenem resistance during the outbreak peroid and six months prior.


During March 2010, a cluster of 6 patients with CRKP was detected. Patients with CRKP were placed under strict contact isolation. Admission and periodic active surveillance cultures showed a downward trend of CRKP clinical cases over the following months to zeros in July and August. All patients had prolonged hospital stay before CRKP detection and the majority had recent history of carbapenem use (75%), colonization/infection with other MDROs (75%), surgical procedures (80%), indwelling devices (83%), and mechanical ventilation (75%). About 33% of patients with CRKP had clinical infection and 58% died during the current hospitalization. PFGE results identified a dominant clone during the outbreak, Figure 1.


Infection control practices are not enough to eliminate the emergence of resistant pathogens. More active interventional methods including an antimicrobial stewardship program would be essential to combat the emergence of multidrug resistant organisms.

Disclosure of interest

None declared.

Authors’ Affiliations

Infection Prevention and Control Department, KAMC
Molecular Department, King Abdullah Internatinal Medical Research Center
Clinical Pathology Department, KAMC
King Faisal Specialist Hospital and Research Center
Department of Medicine, KAMC
Department of Critical Care, KAMC


© Balkhy et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.